Bintel

About Bintel

Bintel develops oncology diagnostic systems designed to identify biologically active disease earlier in the clinical timeline.

Our approach is grounded in translational biology and focuses on liquid biomarkers that reflect tumor activity rather than late structural changes. We prioritize narrow, clinically relevant use cases and build toward validation paths that are compatible with real-world laboratory and pharmaceutical workflows.

Bintel’s work supports clinical research, trial enrichment, and future clinical deployment in defined high-risk populations, with an initial focus on breast and lung oncology.

Keywords

• Cap Table Management
• Equity Tokenization
• Fundraising
• Fundraising Contracts
• Liquid Venture Capital Solutions

Address

• Headquarters

  DelawareUnited States

Team by function

Based on 4 public job profiles as of 3 September 2026.

• Founder / Owner3
• Finance / Accounting1